Calithera biosciences Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Calithera biosciences Contact Number

Tumor Metabolism and Tumor Immunology Contact Calithera

7 hours ago Calithera.com Show details

650 870 1000Calithera Biosciences, Inc. 343 Oyster Point Blvd, Suite 200. South San Francisco, CA 94080. +1 650 870 1000.

1. 343 Oyster Point Blvd Ste 200, South San Francisco, CA 94080

Category: Contact SupportShow more

Calithera Biosciences Company Contact Information Email

Just Now Adapt.io Show details

Get Calithera Biosciences company's verified contact number +1*****615, web address, revenue, total contacts 17, industry Healthcare, Pharmaceuticals, & Biotech and location at Adapt.io

Category: Contact SupportShow more

Calithera Biosciences Crunchbase

1 hours ago Crunchbase.com Show details

(650) 870-1000Contact Email [email protected]Calithera.com Phone Number (650) 870-1000 Calithera is a development stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer.

Founder: Dr Susan M Molineaux

Category: Contact NumberShow more

Calithera Biosciences, Inc. Company Profile

5 hours ago Ir.calithera.com Show details

650.870.1063Investor & Media Contact. Stephanie Wong Chief Financial Officer. 1.650.870.1063 [email protected]Calithera.com

Category: Contact NumberShow more

Calithera Biosciences, Inc. Company Profile South San

9 hours ago Dnb.com Show details

Calithera Biosciences, Inc. is located in South San Francisco, CA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Calithera Biosciences, Inc. has 94 total employees across all of its locations and generates $20.05 …

Category: Contact NumberShow more

Tumor Metabolism and Tumor Immunology Home …

6 hours ago Calithera.com Show details

Calithera Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights July 29, 2021 Calithera Biosciences to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 June 7, 2021 Final Data from Calithera Biosciences’ Phase 2 CANTATA Study in Renal Cell Carcinoma Presented at 2021 ASCO Annual Meeting

Category: Home PhoneShow more

EIN 272366329 Calithera Biosciences, Inc., South San

9 hours ago Eintaxid.com Show details

Calithera Biosciences, Inc. is a corporation in South San Francisco, California. The employer identification number (EIN) for Calithera Biosciences, Inc. is 272366329. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC.

Category: Contact NumberShow more

Culture Calithera

4 hours ago Calithera.com Show details

Calithera is an equal opportunity employer, offering competitive compensation and benefits along with an exciting, supportive and collaborative research and development environment. If you are interested in joining our organization, please review the current open positions below.

Category: Contact NumberShow more

Calithera Biosciences Crunchbase

Just Now Crunchbase.com Show details

Calithera Biosciences has raised a total of $200.9M in funding over 9 rounds. Their latest funding was raised on Nov 2, 2020 from a Grant round. Calithera Biosciences is registered under the ticker NASDAQ:CALA . Calithera Biosciences is funded by 8 investors. Cystic Fibrosis Foundation and Morgenthaler Ventures are the most recent investors.

Category: Contact NumberShow more

Calithera Biosciences hiring Senior Contract Recruiter

3 hours ago Linkedin.com Show details

Calithera Biosciences, Inc. is seeking a highly motivated and self-directed Contract Recruiter to partner with our People Operations team on a significant amount of recruiting.

Category: Contact NumberShow more

Tumor Metabolism and Tumor Immunology About Calithera

5 hours ago Calithera.com Show details

Calithera is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted, small molecule therapies that disrupt cellular metabolic pathways to preferentially block tumor cell growth and enhance immune-cell activity. Tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug

Category: Contact NumberShow more

Calithera Biosciences, Inc. Calithera Biosciences

2 hours ago Ir.calithera.com Show details

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, today announced several executive promotions. The company also …

Category: Contact NumberShow more

Tumor Metabolism and Tumor Immunology Board Calithera

5 hours ago Calithera.com Show details

Dr. Molineaux has served as our President, Chief Executive Officer, and as a member of our board of directors since she co-founded Calithera in 2010. Dr. Molineaux co-founded Proteolix, a biopharmaceutical company, where she served in various roles, including Chief Executive Officer, and Chief Scientific Officer until Proteolix’s acquisition

Category: Contact NumberShow more

Press Releases Calithera Biosciences, Inc.

8 hours ago Ir.calithera.com Show details

650.870.1063Investor & Media Contact. Stephanie Wong Chief Financial Officer. 1.650.870.1063 [email protected]Calithera.com

Category: Contact NumberShow more

Calithera Biosciences Number of Employees Macrotrends

8 hours ago Macrotrends.net Show details

Calithera Biosciences number of employees from 2013 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Events & Presentations Calithera Biosciences, Inc.

5 hours ago Ir.calithera.com Show details

650.870.1063Investor & Media Contact. Stephanie Wong Chief Financial Officer. 1.650.870.1063 [email protected]Calithera.com

Category: Contact NumberShow more

CALITHERA BIOSCIENCES, INC. EDGAR Online

5 hours ago Content.edgar-online.com Show details

125-20-1135CALITHERA BIOSCIENCES, INC. 343 Oyster Point Blvd., Suite 200 . South San Francisco, California 94080 (650) 870-1000. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS . To Be Held On June 9, 2020 . Dear Stockholder: You are cordially invited to attend the Annual Meeting of Stockholders of Calithera Biosciences, Inc., a Delaware corporation (the

Category: Contact NumberShow more

Financial Information Overview Calithera Biosciences, Inc.

8 hours ago Ir.calithera.com Show details

Market Cap (Total, All Common Classes) (Mil) This value is calculated by multiplying the current Price by the current number of Shares Outstanding. 151.19: Shares Outstanding (Total, All Classes) (Mil) This is the number of shares of common stock currently outstanding. This number is defined as the number of shares issued minus the shares held in treasury.

Category: Contact NumberShow more

Calithera Biosciences hiring People Operations Coordinator

9 hours ago Linkedin.com Show details

Please contact Kim Smith at [email protected]calithera.com, and an alternative format will be provided to you so you can access the information in this Notice. 3.3 Changes to this Notice We reserve the

Category: Contact NumberShow more

Senior Contract Recruiter Remote Job in South San

2 hours ago Ziprecruiter.com Show details

Easy 1-Click Apply (CALITHERA BIOSCIENCES INC.) Senior Contract Recruiter - Remote job in South San Francisco, CA. View job description, responsibilities and qualifications. See if you qualify!

Category: Contact NumberShow more

Calithera Biosciences Inc(CALA)股票价格_行情_走势图—东方财富网

9 hours ago Quote.eastmoney.com Show details

提供Calithera Biosciences Inc(CALA)股票的行情走势、五档盘口、逐笔交易等实时行情数据,及Calithera Biosciences Inc(CALA)的资讯、公司公告、研究报告、行业研报、F10资料、行业资讯、资金流分析、阶段涨幅、所属板块、财务指标、机构观点、行业排名、估值水平、股吧互动等与Calithera Biosciences Inc(CALA)有关的

Category: Contact NumberShow more

What Do Analysts Think Of Calithera Biosciences Inc. (CALA

3 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 74.06 million. CALA does have institutional investors; and they hold 67.60% of the stock. Calithera Biosciences Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares.

Category: Contact NumberShow more

People Operations Coordinator (Contract) Job in South San

9 hours ago Ziprecruiter.com Show details

Effective Date: October 13, 2020 Introduction This notice (“Notice”) describes the categories of personal information that Calithera Biosciences, Inc. (“Company”, “we”, “us” and “our”) collects about California residents who apply or are recruited for a job with us or one of our affiliates (“candidates”), and the

Category: Contact NumberShow more

Calithera Biosciences Provides Update on Business Operations

6 hours ago Finance.yahoo.com Show details

SOUTH SAN FRANCISCO, April 14, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (), a clinical stage biotechnology company focused on discovering and developing novel small-molecule drugs for

Category: Contact NumberShow more

calaex101_64.htm

4 hours ago Sec.gov Show details

(650) 870-1000Calithera Biosciences, Inc. 343 Oyster Point Blvd, #200. South San Francisco, CA 94080 (650) 870-1000 (e)Plan Administrator. The Plan Administrator’s contact information is: Calithera Biosciences, Inc. Board of Directors. 343 Oyster Point Blvd, #200. South San Francisco, CA 94080 (650) 870-1000

Category: Contact NumberShow more

Calithera Biosciences, Inc. (CALA) Stock Price, News

5 hours ago Stockstelegraph.com Show details

Calithera Biosciences, Inc. (CALA) Calithera Biosciences, Inc. (CALA) stock rallied over 3.90% intraday to trade at $2.40 share on NASDAQ. The stock opened with a fall of % at $2.31 and touched an intraday high of $2.4200, rising 4.76% against the last close of $2.31. The stock went to a low of $2.3100 during the session.

Category: Contact NumberShow more

Calithera Biosciences and Antengene Enter Yahoo

3 hours ago Finance.yahoo.com Show details

About Calithera Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that …

Category: Contact NumberShow more

Calithera Biosciences Closes $40 Million in Series A Financing

6 hours ago Prnewswire.com Show details

Calithera Biosciences was founded in 2010, with core technologies licensed from the University of California, San Francisco, to develop novel therapeutic approaches to …

Category: Contact NumberShow more

Study of the Glutaminase Inhibitor CB ClinicalTrials.gov

7 hours ago Clinicaltrials.gov Show details

Many tumor cells, in contrast to normal cells, have been shown to require the amino acid glutamine to produce energy for growth and survival. To exploit the dependence of tumors on glutamine, CB-839, a potent and selective inhibitor of the first enzyme in glutamine utilization, glutaminase, will be tested in this Phase 1 study in patients with advanced hematologic malignancies.

Category: Contact NumberShow more

Hedge Funds Are Selling Calithera Biosciences Inc Yahoo

7 hours ago Finance.yahoo.com Show details

Calithera Biosciences Inc (NASDAQ: CALA) has seen a decrease in hedge fund interest of late. CALA was in 12 hedge funds' portfolios at the end …

Category: Contact NumberShow more

Emily Humphrey Research Associate I Calithera Apollo

8 hours ago Apollo.io Show details

View Emily Humphrey's business profile as Research Associate I at Calithera Biosciences. Find Emily's email address, phone number, work history, and more. phone number, work history, and more. Product About Create Free Account. Emily Humphrey's Professional Contact Details. Email (Verified) e**@calithera.com. Get Email Address

Category: Contact NumberShow more

Calithera to Participate in Jefferies Virtual Yahoo

6 hours ago Finance.yahoo.com Show details

SOUTH SAN FRANCISCO, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small

Category: Contact NumberShow more

Calithera Biosciences hiring Clinical Scientist in South

9 hours ago Linkedin.com Show details

Please contact Kim Smith at [email protected]calithera.com, and an alternative format will be provided to you so you can access the information in this Notice. 3.3 Changes to this Notice We reserve the

Category: Contact NumberShow more

FORM D SEC

4 hours ago Sec.gov Show details

650-870-1010Calithera Biosciences, Inc. Street Address 1 Street Address 2; 341 Oyster Point Blvd., Suite 100: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; South SAN FRANCISCO: CALIFORNIA: 94080: 650-870-1010

Category: Contact NumberShow more

Blaze Bioscience Crunchbase

6 hours ago Crunchbase.com Show details

Legal Name Blaze Bioscience, Inc. Company Type For Profit. Contact Email [email protected]blazebioscience.com. Phone Number 2062575924. Blaze Bioscience is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients.

Category: Contact NumberShow more

Study of the Glutaminase Inhibitor CB ClinicalTrials.gov

7 hours ago Clinicaltrials.gov Show details

To exploit the dependence of tumors on glutamine, CB-839, a potent and selective inhibitor of the first enzyme in glutamine utilization, glutaminase, will be tested in this Phase 1 study in patients with leukemia. This study is an open-label Phase 1 evaluation of CB-839 in subjects with leukemia. Part 1 is a dose escalation study to identify

Category: Contact NumberShow more

Calithera Biosciences Provides Update on BioSpace

3 hours ago Biospace.com Show details

SOUTH SAN FRANCISCO, April 14, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small-molecule drugs for the treatment of cancer and other life-threatening diseases, shared an update on business operations, including clinical program adjustments related to COVID-19.

Category: Contact NumberShow more

Susan M. Molineaux President and Chief Crunchbase

1 hours ago Crunchbase.com Show details

Number of Past Jobs 1 Susan M. Molineaux is the President and Chief Executive Officer at Calithera Biosciences . Additionally, Susan M. Molineaux has had 1 past job as the President & Chief Executive Officer at Proteolix .

Category: Contact NumberShow more

Should Calithera Biosciences Inc. (NASDAQ: CALA) Rally

Just Now Marketingsentinel.com Show details

Calithera Biosciences Inc. (NASDAQ:CALA)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.70. At the close of trading, the stock’s price was $2.02, to imply a decrease of 0.00% or $0.0 in intraday trading. The CALA share’s 52-week high rem

Category: Contact NumberShow more

CALA Calithera Biosciences, Inc. Stock Quote FINVIZ.com

6 hours ago Finviz.com Show details

Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States.

Category: Contact NumberShow more

Calithera Biosciences Announces New Employment Yahoo

9 hours ago Finance.yahoo.com Show details

SOUTH SAN FRANCISCO, Calif., July 02, 2020 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (), a clinical stage biotechnology company focused on discovering and developing novel small molecule

Category: Contact NumberShow more

Clinical Biomarker Operations Manager Job in South San

7 hours ago Ziprecruiter.com Show details

Calithera is headquartered in South San Francisco, California.ResponsibilitiesPlans, coordinates, and oversees biomarker sample management and testingOversees sample collection, QC, shipment, receipt, cataloging, storage, and maintenance of bio-sample inventoriesBiomarker vendor management including oversight of scope of work, budgets and

Category: Contact NumberShow more

Buy shares of Calithera Biosciences, Inc. stock (CALA) Stash

2 hours ago Stash.com Show details

How to buy Calithera Biosciences, Inc. stock on Stash. 1. Enter the amount you'd like to invest in Calithera Biosciences, Inc. stock, then proceed to checkout. Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Category: Contact NumberShow more

A Lesson to Learn: Calithera Biosciences Inc. (CALA

3 hours ago Newsheater.com Show details

Calithera Biosciences Inc. (NASDAQ:CALA) went down by -2.38% from its latest closing price compared to the recent 1-year high of $6.18. The company’s stock price has collected -10.48% of loss in the last five trading sessions. Press Release reported on 09/08/21 that Calithera Biosciences to Present Telaglenastat KEAPSAKE Trial in Progress Poster at the IASLC 2021 World Conference on …

Category: Contact NumberShow more

Jean George General Partner Crunchbase

5 hours ago Crunchbase.com Show details

Jean is a General Partner of Lightstone Ventures. She focuses on biopharmaceutical and medical device investments out of the firm’s Boston office, where she also serves as a General Partner of Advanced Technology Ventures (ATV). Her representative investments include Acceleron Pharma (NASDAQ: XLRN), Calithera Biosciences (NASDAQ: CALA), Cyteir

Category: Contact NumberShow more

Calithera Biosciences : Expands Oncology Pipeline with

Just Now Marketscreener.com Show details

2 days ago · SOUTH SAN FRANCISCO, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced an agreement with Takeda Pharmaceutical Company Limited (“Takeda”) to acquire two clinical-stage compounds, both of which have demonstrated single-agent

Category: Contact NumberShow more

Calithera Biosciences : Investor Deck MarketScreener

7 hours ago Marketscreener.com Show details

Calithera Biosciences Inc. published this content on 18 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 October 2021 20:31:05 UTC.

Category: Contact NumberShow more

Investor Confidence Dwindles After Calithera Biosciences

Just Now Marketingsentinel.com Show details

Calithera Biosciences Inc. (NASDAQ:CALA)’s Major holders Insiders own 0.70% of the company shares, while shares held by institutions stand at 67.50% with a share float percentage of 67.98%. Investors are also buoyed by the number of investors in a company, with Calithera Biosciences Inc. having a total of 111 institutions that hold shares in

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Costco
Cisco
Ccu
Cae